EU approves Pfizer-BioNTech vaccine
21 December 2020, 17:44
Deliveries of the vaccine had been pencilled in to start this Saturday.
The European Union has given official approval for the coronavirus vaccine developed by BioNTech and Pfizer to be put on to the market across the 27-nation bloc.
European Commission president Ursula von der Leyen said the commission “took the decision to make available for European citizens the first Covid-19 vaccine. We granted conditional market authorisation”.
The commission, the EU’s executive arm, gave the green light just hours after the European Medicines Agency said the shot meets safety and quality standards.
Today we add an important chapter to a European success story, by making available the 1st #COVID19 vaccine for Europeans.
More will come.
It will be available to all EU countries at the same time, on the same conditions #EUvaccinationdays https://t.co/4Xa17PQkMv
— Ursula von der Leyen (@vonderleyen) December 21, 2020
Brussels had been expected to require two or three days to endorse the market authorisation move.
Deliveries of the vaccine had been pencilled in to start this Saturday, with inoculations beginning across the EU between December 27-29.
